Lusomedicameta's Acquisition

Lusomedicameta was acquired by Recipharm on November 13, 2014.

Lusomedicamenta is primarily a contract development and manufacturing organization (CDMO) specializing in the development and manufacture of solid, liquid and semi-solid dose forms as well as sterile …

Articles about Lusomedicameta's Acquisition: